Benzinga | Nov 3, 2020 04:32PM EST

Supernus Pharmaceuticals Q3 EPS $0.74 Beats $0.30 Estimate, Sales $155.10M Beat $130.66M Estimate

Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly earnings of $0.74 per share which beat the analyst consensus estimate of $0.30 by 146.67 percent. This is a 37.04 percent increase over earnings of $0.54 per share from the same period last year. The company reported quarterly sales of $155.10 million which beat the analyst consensus estimate of $130.66 million by 18.71 percent. This is a 51.85 percent increase over sales of $102.14 million the same period last year.